These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 3260395)
21. Experimental approach of treatment of cerebral ischemia by a combination of raubasine and almitrine. Borzeix MG; Cahn J Arzneimittelforschung; 1987 May; 37(5):491-4. PubMed ID: 2887170 [TBL] [Abstract][Full Text] [Related]
22. [Effect of almitrine/raubasine on cerebral metabolism in the elderly]. Allain H; Bentué-Ferrer D Presse Med; 2002 Mar; 31(12):562-4. PubMed ID: 11984975 [TBL] [Abstract][Full Text] [Related]
23. Double-blind, placebo-controlled quantitative EEG and psychometric studies in elderlies on vigilance-promoting effects of an almitrine/raubasine combination (Duxil). Saletu B; Grünberger J; Linzmayer L; Anderer P Arch Gerontol Geriatr; 1988 Jun; 7(2):93-110. PubMed ID: 3415398 [TBL] [Abstract][Full Text] [Related]
24. [Study of local blood flow and oxidative metabolism of the brain in cerebral ischemia in the human using positron tomography]. Castaigne P Bull Acad Natl Med; 1982 Feb; 166(2):259-74. PubMed ID: 6756582 [No Abstract] [Full Text] [Related]
25. Value of acute-stage positron emission tomography in predicting neurological outcome after ischemic stroke: further assessment. Marchal G; Rioux P; Serrati C; Furlan M; Derlon JM; Viader F; Baron JC Stroke; 1995 Mar; 26(3):524-5. PubMed ID: 7886737 [No Abstract] [Full Text] [Related]
26. Positron tomography in cerebral ischemia. A review. Baron JC Neuroradiology; 1985; 27(6):509-16. PubMed ID: 3878474 [TBL] [Abstract][Full Text] [Related]
27. The pathophysiology of human cerebral ischaemia: a new perspective obtained with positron tomography. Frackowiak RS Q J Med; 1985 Nov; 57(223):713-27. PubMed ID: 3909200 [No Abstract] [Full Text] [Related]
28. [Pharmacology of brain circulation and clinical extrapolations. An experimental study of the circulatory and metabolic effects of Hydrosarpan 711]. Cahn J; Herold M; Borzeix MG Sem Hop Ther; 1974 Dec; 50(10):671-82. PubMed ID: 4465918 [No Abstract] [Full Text] [Related]
29. Assessment of the therapeutic activity of a combination of almitrine and raubasine on functional rehabilitation following ischaemic stroke. Li S; Long J; Ma Z; Xu Z; Li J; Zhang Z Curr Med Res Opin; 2004 Mar; 20(3):409-15. PubMed ID: 15025850 [TBL] [Abstract][Full Text] [Related]
30. Pharmacological features of an almitrine-raubasine combination. Activity at cerebral levels. Benzi G Eur Neurol; 1998; 39 Suppl 1():31-8. PubMed ID: 9516073 [TBL] [Abstract][Full Text] [Related]
31. Use of positron emission tomography scanning in cerebral ischemia. Thomas DG; Gibbs JM; Wise RJ Clin Neurosurg; 1985; 32():51-69. PubMed ID: 3905150 [No Abstract] [Full Text] [Related]
32. Almitrine-Raubasine combination for dementia. Yang W; Liu M; Teng J; Hao Z; Wu B; Wu T; Liu GJ Cochrane Database Syst Rev; 2011 Mar; (3):CD008068. PubMed ID: 21412915 [TBL] [Abstract][Full Text] [Related]
33. [Exploration of the effects of duxil on the central nervous system by quantified electroencephalography]. Sebban C Rev Med Interne; 1988 Feb; 9(1):58-62. PubMed ID: 3387703 [No Abstract] [Full Text] [Related]
38. [Psychometric evaluation of the effects of an almitrine-raubasine combination in the intellectual deterioration of aged subjects. A double-blind controlled trial versus placebo]. Rapisarda V; Azzaro E; Fichera G Presse Med; 1987 Jun; 16(23):1163-6. PubMed ID: 2885827 [TBL] [Abstract][Full Text] [Related]
39. Positron emission tomography and its application to the study of cerebrovascular disease in man. Powers WJ; Raichle ME Stroke; 1985; 16(3):361-76. PubMed ID: 3890277 [No Abstract] [Full Text] [Related]
40. [Positron emission tomography in the physiopathological study of cerebral ischemia in man]. Baron JC; Bousser MG; Comar D; Rougemont D; Lebrun-Grandié P; Castaigne P Presse Med; 1983 Dec; 12(48):3066-72. PubMed ID: 6228916 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]